{
    "2020-09-14": [
        [
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报：三个机遇和一个可控风险 把握医药反弹的主线",
                "features": {
                    "keywords": [
                        "医药生物",
                        "跨市场",
                        "机遇",
                        "可控风险",
                        "反弹",
                        "主线"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}